Keywords: further, data, support, tracleer, efficacy, pah, swiss

Further data support Tracleer efficacy in PAH

Article | 02 May 2001

Print This

Swiss biotechnology firm Actelion and US partner Genentech have reportedthe results of a Phase III trial which confirm the efficacy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in